KAP1 SUMOylates and stabilizes SR-A to facilitate glycated LDL transcytosis and accelerate atherosclerosis
Meng Shu, Wenzhuo Cheng, Fangyang Yu, Liyin Zhang, Li Wang, Yan Shu, Ruonan Wang, Baorui Xue, Si Jin · 2026
Read KAP1 SUMOylates and stabilizes SR-A to facilitate glycated LDL transcytosis and accelerate atherosclerosis by Meng Shu, Wenzhuo Cheng, Fangyang Yu, Liyin Zhang, Li Wang, Yan Shu, Ruonan Wang, Baorui Xue, Si Jin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13435427.txt.
Description
Meng Shu's team traced in 2026 how sugared LDL cholesterol speeds artery disease through a receptor called SR-A. Sugared LDL collects under vessel linings and raises SR-A, which then ferries more of it across endothelial cells, feeding plaque growth, but the step that raises SR-A was unclear. In human vessel cells and mice lacking ApoE, the team showed a protein called KAP1 binds SR-A and adds a SUMO tag that blocks its breakdown.
Cutting KAP1 lowered SR-A activity, cut sugared LDL retention in aortas, and reduced fragile plaque in mice. The paper thus names KAP1 as a lever that steadies SR-A and accelerates disease in diabetes-linked artery harm. Vascular teams get a precise mechanism and a target for drugs that might slow plaque by letting SR-A degrade.
Catalog record
| CREATOR | Meng Shu, Wenzhuo Cheng, Fangyang Yu, Liyin Zhang, Li Wang, Yan Shu, Ruonan Wang, Baorui Xue, Si Jin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |